Trial Profile
Comparison of the pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination with clopidogrel and aspirin alone in patients treated with coronary stents
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Aspirin/clopidogrel (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- Acronyms ACCEL-COMBO
- 26 Apr 2017 New trial record
- 01 Mar 2017 Results published in the Platelets